Hint mode is switched on Switch off
For swift navigation between sections

20/20 Biolabs
LEI 5493002L38RIRZD5JQ11

PDF download

Choose all Reset all
Download Cancel
Organization name
20/20 Biolabs, Inc.
Country name
USA
Country of registration
USA
Industry
Professional Services
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

20/20 Biolabs Inc, formerly 20/20 GeneSystems, Inc., is a digital diagnostics company, which is engaged in developing and commercializing clinical laboratory tests and associated software that is powered by machine learning and real-word data to improve diagnostic accuracy and clinical usefulness. The Company offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.

Awards

News

26/05/2026 20/20 Biolabs: Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
20/05/2026 20/20 Biolabs: Results Of Operations And Financial Condition, Financial Statements And Exhibits
28/04/2026 20/20 Biolabs: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493002L38RIRZD5JQ11
  • SIC
    8734 SERVICES-TESTING LABORATORIES
  • CIK
    0001139685
  • EIN
    52-2272107
Registration is required to get access.